×

Confirmation for an individual

×

Confirmation for a legal entity

About us

Association of Genetic Therapy, z.s. is a voluntary organization of patients and professionals whose aim is to support the research on potential treatment of rare genetic disorders such as Angelman syndrome (AS). We bring together experts, public, families and organizations to find the ways of financing research in the area of rare diseases. The research has been started and is led by a member of our scientific board – Assoc. prof. Radislav Sedláček, PhD. - Director of the Czech Center for Phenogenomics.


This research has the potential to discover functioning mechanisms of many more related conditions such as Autism, Rett syndrome, Prader-Willi syndrome and Alzheimer. We want to bridge the medical findings from human genetics of real patients with the basic research on mouse models to accelerate research by making more accurate research models and bring practical treatment of the genetic diseases into the medical practice as quickly as possible.


The Association of Genetic Therapy, z.s. was founded in July 2018 after our son was diagnosed Angelman syndrome. This rare genetic disorder (about 50 patients in the Czechia and Slovakia) is causing mental retardation, absent of speech, lagging in motor skills, epilepsy and other unpleasant symptoms. People with AS are during whole life dependent on the help of others. This condition is caused by fault in DNA on the 15th chromosome. We initiated basic research on potential treatment of this syndrome in the Czech Republic.

Oliver´s story

PF2019

PF2019

23. 1. 2019 Happiness from life, good health, many personal and professional successes in 2019 we wish to  all our donors, everybody who support our project in last year,  everybody who visited our website and started to be interested in our project,  everybody...

Read more
When you first hear the diagnosis

When you first hear the diagnosis

1. 3. 2018 It all began at the beginning of February 2018 on the day we were announced Oliver's diagnosis. A rare genetic defect, the so-called Angelman syndrome, an incurable disease at this time. I never forget the moment when I first read...

Read more

News from research

Introducing our partner – the international company DNV GL

Introducing our partner – the international company DNV...

4. 9. 2019 DNV GL is global independent services provider in the area of risk management, certification, validation, verification and trainings in all industry sectors with a special focus on healthcare. Last year company DNV GL decided to support our nonprofit organisation ASGENT.ORG. We...

Read more
Media Press – APO Bulletin (01)/08-2019

Media Press – APO Bulletin (01)/08-2019

29. 8. 2019 In August 2019, the first monthly newsletter of the Academy of Patient Organizations (APO) was published. The Academy of Patient Organizations which we are a member of, is an educational and development project designed for Czech patients organisations. Its pursuit...

Read more